CCJ-38457-88676
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 982 / WA
- Registered
- 2022-06-22
- Relationship
- Child or adolescent in my care
- Guardian
- C8R-31883-66755
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Registered in v-safe
-
2022-07-10
Dose 1 — Moderna
- 2022-07-11
- 2022-07-12
- 2022-07-17
- 2022-07-26
-
2022-08-07
Dose 2 — Moderna
-
2022-08-08
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Fever · Loss of appetiteUnder 3 check-in
- 2022-08-10
- 2022-08-11
- 2022-08-13
- 2022-08-21
- 2022-08-30
- 2022-09-11
- 2022-09-19
-
2022-11-08
Survey response — 3 months, dose 2, under 3MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: RsvMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-10 | Moderna | No |
| 2 | 2022-08-07 | Moderna | No |
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Rsv
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release